Canaccord analyst George Gianarikas lowered the firm’s price target on Enovix (ENVX) to $21 from $22 and keeps a Buy rating on the shares. The firm noted the quarter introduced another delay in the “hockey stick” P&L they have been anticipating and tell investors to continue to be patient.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ENVX:
- Enovix price target lowered to $21 from $22 at Canaccord
- Enovix’s Strategic Partnership with Honor: A Buy Rating Amidst Challenges and Opportunities
- Enovix Corporation Reports Strong Q3 2025 Results
- Enovix sees Q4 non-GAAP EPS (16c)-(20c), consensus (14c)
- Enovix reports Q3 EPS (14c), consensus (16c)